NCT01252160View on ClinicalTrials.gov

Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage

PHASE4CompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

October 28, 2010

Primary Completion Date

September 26, 2013

Study Completion Date

September 26, 2013

Conditions
Neuralgia, Postherpetic
Interventions
DRUG

QUTENZA

Cutaneous patch

Trial Locations (64)

9

Dublin

1000

Brussels

Ljubljana

1090

Vienna

1160

Vienna

2000

Antwerp

2650

Edegem

3435

Nieuwegein

3600

Genk

4270

Jesenice

7623

Pécs

8011

Zwolle

8025

Barcelona

Cataluna

8800

Roeselare

11528

Athens

15405

Ferrol

18014

Granada

20132

Milan

27100

Pavia

28006

Madrid

28034

Madrid

29010

Málaga

33100

Tampere

37007

Salamanca

42055

Saint-Etienne

47900

Rimini

48903

Barakaldo

54642

Athens

66100

Chieti

75012

Paris

75018

Paris

75651

Paris

80131

Naples

85028

Rionero in Vulture

85107

Bratislava

90146

Palermo

92100

Boulogne-Billancourt

98039

Taormina

300723

Timișoara

625 00

Brno-Bohunice

304 60

Plzen-Lochotin

150 06

Prague

180 81

Prague

00280

Helsinki

06002

Nice

Unknown

Cork

Bucharest

00149

Roma

85-094

Bydgoszcz

40-662

Katowice

94-238

Lodz

00-416

Warsaw

08025

Badalona

08035

Barcelona

BN2 1ES

Brighton

EH4 2XU

Edinburgh

G12 0YN

Glasgow

L97LJ

Liverpool

E11BB

London

SE1 7EH

London

SW10 9NH

London

SW17 0QT

London

B91 2LJ

Solihull

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY